HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 2, 2026 is 79.09 B VND. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 99.22 B VND — a change of -20.29% (lower).

EBITDA

79.09 BVND

YoY

-20.29%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HaTay Pharmaceutical JSC is 2024 79.09 B VND. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HaTay Pharmaceutical JSC was 2023 99.22 B VND. It decreases by -20.29% lower compared to the previous year.

The HaTay Pharmaceutical JSC EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
88.54 B VND
Jan 1, 2018
91.84 B VND
Jan 1, 2019
101.14 B VND
Jan 1, 2020
113.28 B VND
Jan 1, 2021
65.46 B VND
Jan 1, 2022
105.60 B VND
Jan 1, 2023
99.22 B VND
Jan 1, 2024
79.09 B VND
The HaTay Pharmaceutical JSC EBITDA history
YEAREBITDAYoY
79.09 BVND-20.29%
99.22 BVND-6.05%
105.60 BVND+61.31%
65.46 BVND-42.21%
113.28 BVND+12.00%
101.14 BVND+10.13%
91.84 BVND+3.73%
88.54 BVND+34.28%
65.93 BVND+28.26%
51.41 BVND+33.67%
38.46 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HaTay Pharmaceutical JSC is 79.09 B VND in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HaTay Pharmaceutical JSC changed from 99.22 B VND to 79.09 B VND, representing a -20.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s HaTay Pharmaceutical JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — HaTay Pharmaceutical JSC

All Key Metrics — HaTay Pharmaceutical JSC